Skip to main content
SpringerLink
Log in

Superantigens in Human Disease

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Superantigens have been implicated in a wide variety of human diseases. Yet, solid evidence for their role in pathogenesis is available only for Toxic Shock Syndrome and a few other conditions. This evidence is critically reviewed herein.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Bohach GA, Fast DJ, Nelson RD, Schlievert PM: Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 17:251–272, 1990

    Google Scholar 

  2. Rott O, Fleischer B: A superantigen as virulence factor in an acute bacterial infection. J Infect Dis 169:1142–1146, 1994

    Google Scholar 

  3. Held W, Waanders GA, Shakhov AN, Scarpellino L, Acha-Orbea H, MacDonald HR: Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529–540, 1993

    Google Scholar 

  4. Ross SR: Mouse mammary tumor virus and its interaction with the immune system. Immunol Res 17:209–216, 1998

    Google Scholar 

  5. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P: The Vb-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 57:27–35, 1989

    Google Scholar 

  6. Festenstein H: Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse. Transplant Rev 15:62–88, 1973

    Google Scholar 

  7. Langford MP, Stanton GJ, Johnson HM: Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun 22:62–68, 1978

    Google Scholar 

  8. Proft T, Moffatt SL, Berkahn CJ, Fraser JD: Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med 189:89–101, 1999

    Google Scholar 

  9. Mehindate K, Thibodeau J, Dohlsten M, Kalland T, Sekaly RP, Mourad W: Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J Exp Med 182:1573–1577, 1995

    Google Scholar 

  10. Chatila T, Geha RS: Signal transduction by microbial superantigens via MHC class II molecules. Immunol Rev 131:43–60, 1993

    Google Scholar 

  11. Thibodeau J, Cloutier I, Lavoie PM, et al.: Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science 266:1874–1878, 1994

    Google Scholar 

  12. Yagi J, Nakata M, Uchiyama T, et al.: Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor. J Immunol 152:3833–3841, 1994

    Google Scholar 

  13. Ratcliffe MJ, Coggeshall KM, Newell MK, Julius MH: T cell receptor aggregation, but not dimerization, induces increased cytosolic calcium concentrations and reveals a lack of stable association between CD4 and the T cell receptor. J Immunol 148:1643–1651, 1992

    Google Scholar 

  14. Currier JR, Yassai M, Robinson MA, Gorski J: Molecular defects in TCRBV genes preclude thymic selection and limit the expressed TCR repertoire. J Immunol 157:170–175, 1996

    Google Scholar 

  15. Wei S, Charmley P, Robinson MA, Concannon P: The extent of the human germline T-cell receptor V beta gene segment repertoire. Immunogenetics 40:27–36, 1994

    Google Scholar 

  16. Levinson AI, Kozlowski LM: B-cell superantigens and their biological implications. In Superantigens: Molecular Biology, Immunology and Relevance to Human Disease, DYM Leung, BT Huber, PM Schlievert (eds). New York, Marcel Dekker, 1997, p 405

    Google Scholar 

  17. Zabriskie JB: The role of temperate bacteriophage in the production of erythrogenic toxin by group A streptococci. J Exp Med 119:761, 1964

    Google Scholar 

  18. Fleischer B, Necker A, Leget C, Malissen B, Romagne F: Reactivity of mouse T-cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens. Infect Immun 64:987–994, 1996

    Google Scholar 

  19. Fleischer B, Bailey CJ: Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen. Med Microbiol Immunol (Berl) 180:273–278, 1992

    Google Scholar 

  20. Fleischer B, Hartwig U: T lymphocyte stimulation by microbial superantigens. In Biological Significance of Superantigens, B Fleischer (ed). Basel, Karger, 1992, p 36

    Google Scholar 

  21. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B: A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 90:303–313, 1997

    Google Scholar 

  22. Huang Z, Vafai A, Lee J, Mahalingam R, Hayward AR: Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4+ human T-cell clones. J Virol 66:2664–2669, 1992

    Google Scholar 

  23. Oxman MN: Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 45:S41-S46, 1995

    Google Scholar 

  24. Nader S, Bergen R, Sharp M, Arvin AM: Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J Infect Dis 171:13–17, 1995

    Google Scholar 

  25. McCormack JE, Callahan JE, Kappler J, Marrack PC: Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 150:3785–3792, 1993

    Google Scholar 

  26. Kotzin BL, Leung D, Kappler J, Marrack P: Superantigens and their potential role in human disease. Adv Immunol 54:99–166, 1993

    Google Scholar 

  27. Choi Y, Lafferty JA, Clements JR, et al.: Selective expansion of T cells expressing Vb2 in toxic shock syndrome. J Exp Med 172:981–984, 1990

    Google Scholar 

  28. Watanabe-Ohnishi R, Low DE, McGeer A, et al.: Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project [see comments]. J Infect Dis 171:74–84, 1995

    Google Scholar 

  29. Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P: Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:261–270, 1995

    Google Scholar 

  30. Vella AT, Mitchell T, Groth B, et al.: CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. J Immunol 158:4714–4720, 1997

    Google Scholar 

  31. Biasi G, Panozzo M, Pertile P, Mezzalira S, Facchinetti A: Mechanism underlying superantigen-induced clonal deletion of mature T lymphocytes. Int Immunol 6:983–989, 1994

    Google Scholar 

  32. McCormack JE, Kappler J, Marrack P: Stimulation with specific antigen can block superantigen-mediated deletion of T cells in vivo. Proc Natl Acad Sci USA 91:2086–2090, 1994

    Google Scholar 

  33. Jupin C, Anderson S, Damais C, Alouf JE, Parant M: Toxic shock syndrome toxin as an inducer of human tumor necrosis factors and γ-interferon. J Exp Med 167:752–761, 1988

    Google Scholar 

  34. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H: T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor. J Exp Med 175:91–98, 1992

    Google Scholar 

  35. Hackett SP, Stevens DL: Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. J Infect Dis 168:232–235, 1993

    Google Scholar 

  36. Miethke T, Wahl C, Regele D, Gaus H, Heeg K, Wagner H: Superantigen mediated shock: A cytokine release syndrome. Immunobiology 189:270–284, 1993

    Google Scholar 

  37. Bradley GS, Campbell YG, Castle RM, Grove SA: Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1. Infect Immun 67:1521–1525, 1999

    Google Scholar 

  38. Bette M, Schafer MK-H, van Rooijen N, Weihe E. Fleischer B: Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen J Exp Med 1993; 178:1531–1540.

    Google Scholar 

  39. Marrack P, Blackman M, Kushnir E, Kappler J: The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med 171:455–464, 1990

    Google Scholar 

  40. Miethke T, Duschek K, Wahl C, Heeg K, Wagner H: Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur J Immunol 23:1494–1500, 1993

    Google Scholar 

  41. Trede NS, Geha RS, Chatila T: Transcriptional activation of IL-1 beta and tumor necrosis factor-alpha genes by MHC class II ligands. J Immunol 146:2310–2315, 1991

    Google Scholar 

  42. Abe J, Takeda T: Characterization of a superantigen produced by Yersinia Pseudotuberculosis. In Superantigens: Molecular Biology, Immunology, and Relevance to Human Disease, DYM Leung, BT Huber, PM Schlievert (eds). New York, Marcel Dekker, 1997, p 369

    Google Scholar 

  43. Leung DYM, Schlievert PM: Superantigens in human disease: Future directions in therapy and illucidation of disease pathogenesis. In Superantigens, DYM Leung, BT Huber, PM Schlievert (eds). New York, Marcel Dekker, 1997, p 581

    Google Scholar 

  44. Bonventre PF, Heeg H, Cullen C, Lian CJ: Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect Immun 61:793–799, 1993

    Google Scholar 

  45. de Azavedo JC, Foster TJ, Hartigan PJ, et al.: Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model. Infect Immun 50:304–309, 1985

    Google Scholar 

  46. Tracey KJ, Beutler B, Lowry SF, et al.: Shock and tissue injury induced by recombinant human cachectin. Science 234:470–474, 1986

    Google Scholar 

  47. Miethke T, Wahl C, Wagner H: Role of cytokines/lymphokines in Gram-positive bacterial infections. In Human Cytokines: Their Role in Disease and Therapy, BB Aggarwal, RK Puri (eds). Cambridge, MA, Blackwell Science, 1995, p 371

    Google Scholar 

  48. Chapman PB, Lester TJ, Casper ES, et al.: Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. J Clin Oncol 5:1942–1951, 1987

    Google Scholar 

  49. Pfeffer K, Matsuyama T, Kundig TM, et al.: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457–467, 1993

    Google Scholar 

  50. Zembowicz A, Vane JR: Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line. Proc Natl Acad Sci USA 89:2051–2055, 1992

    Google Scholar 

  51. MacMicking JD, Nathan C, Hom G, et al: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase published erratum appears in Cell 1995 Jun 30;81(17): following 1170]. Cell 81:641–650, 1995

    Google Scholar 

  52. Beutler B, Cerami A: The biology of cachectin/TNF—A primary mediator of the host response. Annu Rev Immunol 7:625–655, 1989

    Google Scholar 

  53. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA: Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 81:1162–1172, 1988

    Google Scholar 

  54. Montegut W, Lowry SF, Moldawer LL: Role of cytokines in septic shock and shock-related syndromes. In Human Cytokines: Their Role in Disease and Therapy, BB Aggarwal, RK Puri (eds). Cambridge, MA, Blackwell Science, 1995, p 381

    Google Scholar 

  55. Smith JW, Urba WJ, Curti BD, et al.: The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. J Clin Oncol 10:1141–1152, 1992

    Google Scholar 

  56. Beutler B, Beutler S: The pathogenesis of fever. In Cecil Textbook of Medicine, JB Wyngaarden, LH Smith, JC Bennet (eds). Philadelphia, W. B. Saunders, 1992, p 1568

    Google Scholar 

  57. Brysk MM, Bell T, Hoida C, Tyring SK, Rajaraman S: Interferon-gamma modulates terminal differentiation and the expression of desquamin in cultured keratinocytes. Exp Cell Res 197:140–147, 1991

    Google Scholar 

  58. Brysk MM, Bell T, Brysk H, Selvanayagam P, Rajaraman S: Enzymatic activity of desquamin. Exp Cell Res 214:22–26, 1994

    Google Scholar 

  59. Rosenberg SA, Lotze MT, Muul LM, et al.: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316:889–897, 1987

    Google Scholar 

  60. Ortho Multicenter Transplant Study Group: A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 313:337–342, 1985

    Google Scholar 

  61. Stevens DL: The toxic shock syndromes. Infect Dis Clin North Am 10:727–746, 1996

    Google Scholar 

  62. Dohlsten M, Hedlund G, Segren S, et al.: Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: Evidence for a novel enterotoxin receptor. Eur J Immunol 21:1229–1233, 1991

    Google Scholar 

  63. Alber G, Hammer DK, Fleischer B: Relationship between enterotoxic-and T lymphocyte-stimulating activity of staphylococcal enterotoxin B. J Immunol 144:4501–4506, 1990

    Google Scholar 

  64. Reck B, Scheuber PH, Londong W, Sailer-Kramer B, Bartsch K, Hammer DK: Protection against the staphylococcal enterotoxin-induced intestinal disorder in the monkey by anti-idiotypic antibodies. Proc Natl Acad Sci USA 85:3170–3174, 1988

    Google Scholar 

  65. Harris TO, Grossman D, Kappler JW, Marrack P, Rich RR, Betley MJ: Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun 61:3175–3183, 1993

    Google Scholar 

  66. Rogers TJ, Guan L, Zhang L: Characterization of an alternative superantigen binding site expressed on a renal fibroblast cell line. Int Immunol 7:1721–1727, 1995

    Google Scholar 

  67. Hamad ARA, Marrack P, Kappler JW: Transcytosis of staphylococcal superantigen toxins. J Exp Med 185:1447–1454, 1997

    Google Scholar 

  68. Lionetti P, Spencer J, Breese EJ, Murch SH, Taylor J, MacDonald TT: Activation of mucosal V beta 3+ T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. Eur J Immunol 23:664–668, 1993

    Google Scholar 

  69. Spiekermann GM, Nagler-Anderson C: Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. J Immunol 161:5825–5831, 1998

    Google Scholar 

  70. McKay DM, Benjamin MA, Lu J: CD4+ T cells mediate superantigen-induced abnormalities in murine jejunal ion transport. Am J Physiol 275:G29-G38, 1998

    Google Scholar 

  71. McKay DM, Singh PK: Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: Inhibition of increased permeability, but not diminished secretory responses by TGF-beta2. J Immunol 159:2382–2390, 1997

    Google Scholar 

  72. Chapman PB, Kolitz JE, Hakes TB, et al.: A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma. Invest New Drugs 6:179–188, 1988

    Google Scholar 

  73. Ohmen JD, Barnes PF, Grisso CL, Bloom BR, Modlin RL: Evidence for a superantigen in human tuberculosis. Immunity 1:35–43, 1994

    Google Scholar 

  74. Cohen-Tervaert JW, Popa ER, Bos NA: The role of superantigens in vasculitis. Curr Opin Rheumatol 11:24–33, 1999

    Google Scholar 

  75. Leung DY, Travers JB, Giorno R, et al.: Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 96:2106–2112, 1995

    Google Scholar 

  76. Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L: Psoriasis: A T-cell-mediated autoimmune disease induced by streptococcal superantigens? [see comments]. Immunol Today 16:145–149, 1995

    Google Scholar 

  77. Dobrescu D, Ursea B, Pope M, Asch AS, Posnett DN: Enhanced HIV-1 replication in Vb12 T cells due to human cytomegalovirus in monocytes: Evidence for a putative herpesvirus superantigen. Cell 82:753–763, 1995

    Google Scholar 

  78. Sutkowski N, Palkama T, Ciurli C, Sekaly R-P, Thorley-Lawson DA, Huber BT: An Epstein-Barr virus associated superantigen. J Exp Med 184:971–980, 1996

    Google Scholar 

  79. Posnett DN: Viral superantigens in humans. A potential role in HIV and CMV infection. In Superantigens: Structure, Biology and Relevance to Human Disease, DYM Leung, B Huber, P Schlievert (eds). New York, Marcel Dekker, 1997, p 503

    Google Scholar 

  80. Lafon M: Superantigen in rabies virus and its involvement in paralysis. In Superantigens, DYM Leung, B Huber, P Schlievert (eds). New York, Marcel Dekker, 1997, p 85

    Google Scholar 

  81. Tsiagbe VK, Asakawa J, Miranda A, Sutherland RM, Paterson Y, Thorbecke GJ: Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells. J Immunol 150:5519–5528, 1993

    Google Scholar 

  82. Tsiagbe VK, Yoshimoto T, Asakawa J, Cho SY, Meruelo D, Thorbecke GJ: Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J 12:2313–2320, 1993

    Google Scholar 

  83. Monday SR, Vath GM, Witold AF, et al.: Unique superantigen activity of staphylococcal exfoliative toxins. J Immunolo 162:4550–4559, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunology Program, Graduate School of Medical Sciences, and Department of Medicine, Division of Hematology–Oncology, Cornell University, Weill Medical College, 1300 York Avenue, Box 56, New York, New York, 10021

    Alejandro Bernal & David N. Posnett

  2. Department of Molecular Medicine, University of Auckland, Auckland, New Zealand

    Thomas Proft & John D. Fraser

Authors
  1. Alejandro Bernal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Proft
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John D. Fraser
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David N. Posnett
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bernal, A., Proft, T., Fraser, J.D. et al. Superantigens in Human Disease. J Clin Immunol 19, 149–157 (1999). https://doi.org/10.1023/A:1020547509410

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020547509410

Search

Navigation